Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Gainesville, FL
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Gainesville, FL
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Hollywood, FL
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Hollywood, FL
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Jacksonville Beach, FL
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Jacksonville Beach, FL
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Miami, FL
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Ocala, FL
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Ocala, FL
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Ponte Verda, FL
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Ponte Verda, FL
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Conyers, GA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Conyers, GA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Aurora, IL
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Aurora, IL
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Chicago, IL
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Chicago, IL
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Melrose Park, IL
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Melrose Park, IL
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Avon, IN
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Avon, IN
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Franklin, IN
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Franklin, IN
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Greenfield, IN
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Greenfield, IN
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Valparaiso, IN
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Valparaiso, IN
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Iowa City, IA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Iowa City, IA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
West Des Moines, IA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
West Des Moines, IA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Crestview Hills, KY
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Crestview Hills, KY
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Lafayette, LA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Lafayette, LA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
New Iberia, LA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
New Iberia, LA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Slidell, LA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Slidell, LA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Auburn, ME
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Auburn, ME
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Bangor, ME
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Bangor, ME
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Scarborough, ME
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Scarborough, ME
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Baltimore, MD
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Oxon Hill, MD
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Oxon Hill, MD
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Prince Frederick, MD
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Prince Frederick, MD
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Natick, MA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Natick, MA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Springfield, MA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Springfield, MA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Cadillac, MI
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Cadillac, MI
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Detroit, MI
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Detroit, MI
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Petoskey, MI
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Petoskey, MI
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
St. Cloud, MN
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
St. Cloud, MN
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
St Louis, MO
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
St Louis, MO
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Browns Mills, NJ
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Browns Mills, NJ
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Elizabeth, NJ
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Elizabeth, NJ
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
West Orange, NJ
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
West Orange, NJ
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Buffalo, NY
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Buffalo, NY
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Westfield, NY
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Westfield, NY
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Williamsville, NY
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Williamsville, NY
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Charlotte, NC
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Gastonia, NC
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Gastonia, NC
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Matthews, NC
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Matthews, NC
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Salisbury, NC
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Salisbury, NC
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Statesville, NC
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Statesville, NC
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Wilmington, NC
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Wilmington, NC
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Grand Forks, ND
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Grand Forks, ND
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Elyria, OH
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Elyria, OH
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Garfield Heights, OH
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Garfield Heights, OH
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Kettering, OH
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Kettering, OH
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Middleburg Heights, OH
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials